Vityala Yethindra, Ainura Dzhangazieva, Zhyldyz Kurzhunbaeva, Tugolbai Tagaev and Furquan Nazami 2020. VYTR hypothesis for the prophylactic and therapeutic efficacy of GS-5734 treatment in humans with COVID-19. International Journal of Research in Pharmaceutical Sciences. 11, (SPL 1) (Apr. 2020), 19–22.